SLAPX | SLARX | SLAPX / SLARX | |
Total Expense Ratio | 2.18 | 1.18 | 185% |
Annual Report Gross Expense Ratio | 2.35 | 1.33 | 177% |
Fund Existence | 24 years | 11 years | - |
Gain YTD | 33.214 | 34.074 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 281M | 281M | 100% |
Annual Yield % from dividends | 3.38 | 4.23 | 80% |
Returns for 1 year | 8.45 | 9.48 | 89% |
Returns for 3 years | 20.84 | 24.46 | 85% |
Returns for 5 years | 42.11 | 50.52 | 83% |
Returns for 10 years | 109.18 | 132.84 | 82% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
REPSX | 37.85 | 0.37 | +0.99% |
ProFunds Real Estate UltraSector Svc | |||
FIJYX | 33.12 | 0.29 | +0.88% |
Fidelity Advisor Biotechnology Z | |||
FACPX | 43.45 | -0.11 | -0.25% |
Fidelity Advisor Consumer Discret M | |||
PCAQX | 87.40 | -0.22 | -0.25% |
Principal Capital Appreciation R5 | |||
TMIFX | 11.23 | -0.06 | -0.53% |
Transamerica Mid Cap Growth R4 |